Scienture Holdings, Inc. SCNX
2.28 USD -0.16 (-6.45%)
Regular-session close
2.19 -0.09 -3.86%
After hours · Nov 20, 4:00 PM ET
2.00 Day range 2.37
2.28 52-week range 16.30
- YTD
- -82.13%
- 1 year
- -83.67%
No chart data for this range yet.
- Market cap
- 4.07M
- Revenue (ttm)
- -351.61K
- EPS (ttm)
- -51.70
- Shares out
- 8.73M
- YTD return
- -82.13%
- 1-year return
- -83.67%
- Volume
- 29.86K
- Avg volume
- 156.18K
- Open
- 2.36
- Previous close
- 2.44
- Day's range
- 2.00 – 2.37
- 52-week range
- 2.28 – 16.30
Key statistics
- 50-day average
- 7.66
- 200-day average
- 9.36
- Enterprise value
- 67.40M
- Price / sales
- -187.96
- Price / book
- 0.77
- Revenue growth
- -83.50%
- Total cash
- 579.10K
- Total debt
- 2.76M
- Short % of float
- 0.07%
Fundamental scorecard
6 of 25 checks passed on SCNX’s reported financials
6of 25 checks passed
- Value 2 of 5
- Growth 2 of 5
- Profitability 0 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
SCNX Revenue — quarterly 1.25M
SCNX Net income — quarterly -6.01M
SCNX EPS — quarterly -3.76
About Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies. Scienture Holdings, Inc. is headquartered in Tampa, Florida.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- scienture.com
News
SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™ Scienture Holdings Q3 EPS $(3.76) Misses $(1.57) Estimate, Sales $1.255M Beat $1.220M Estimate
12 Health Care Stocks Moving In Thursday's After-Market Session Maxim Group Maintains Buy on Scienture Holdings, Adjusts Price Target To $6 (reverse stock split 1:25)
Scienture Holdings Reports Preliminary Q3 Revenue Growth To $1.22M; Co Targeting Profitability In 2027
Your note
Sign in to keep a note on SCNX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AJJARAPU SURENDRA K | Chief Executive Officer | Stock Award(Grant) | Jan 4, 2024 | 0 |
| NEWELL A. JEFFREY | Director | Stock Award(Grant) | Dec 29, 2022 | 79,062 |
| PATEL PRASHANT | Chief Financial Officer | Stock Award(Grant) | Jan 4, 2024 | 0 |
| PETERSON MICHAEL L | Director | Stock Award(Grant) | Jan 12, 2023 | 118,940 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 0.24% | 20,500 | 155.19K | Sep 29, 2024 |
| Vanguard Group Inc | 0.17% | 14,548 | 110.13K | Sep 29, 2024 |
| UBS Group AG | 0.05% | 3,876 | 29.34K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.01% | 664 | 5.03K | Sep 29, 2024 |
| Blue Trust, Inc. | 0.00% | 357 | 2.70K | Sep 29, 2024 |
| Wells Fargo & Company | 0.00% | 9 | 68 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.17% | 14,548 | 110.13K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.04% | 3,529 | 26.71K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 2,004 | 15.17K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 945 | 7.15K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,027 | 7.77K | Oct 30, 2024 |
